ANRO Competitors & Alternatives
Compare Alto Neuroscience, Inc. with similar stocks in the same industry
Biotechnology
ANRO
Main Stock$25.31
Tradestie Score
65
Market Cap
$110.20M
Analyst Upside
+51.6%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
PHAR
Pharming Group N.V. ADS, each representing 10 ordinary shares
|
$9.95
|
$1.05B | 71.4 | 43 | Compare |
|
ANL
ANL
|
$15.76
|
$1.03B | - | 45 | Compare |
|
MDXG
MiMedx Group, Inc
|
$4.64
|
$1.01B | 116.5 | 51 | Compare |
|
PRME
Prime Medicine, Inc. Common Stock
|
$2.99
|
$996.55M | - | 73 | Compare |
|
SYRE
Spyre Therapeutics, Inc. Common Stock
|
$89.93
|
$994.20M | - | 62 | Compare |
|
VALN
Valneva SE American Depositary Shares
|
$5.90
|
$993.46M | - | 53 | Compare |
|
IMNM
Immunome, Inc.
|
$20.89
|
$987.09M | - | 54 | Compare |
|
SANA
Sana Biotechnology, Inc. Common Stock
|
$2.89
|
$951.83M | - | 71 | Compare |
|
MNMD
Mind Medicine (MindMed) Inc. Common Shares
|
$15.02
|
$938.16M | - | 43 | Compare |
|
ZBIO
Zenas BioPharma, Inc. Common Stock
|
$27.94
|
$931.48M | - | 64 | Compare |
More ANRO Analysis
Data updated: Oct 02, 2026 | Industry: Biotechnology (SIC 2834)
230 stocks in this industry